Geode Capital Management
VAXX

Geode Capital Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Geode Capital Management’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-878,543
Closed -$630K – 4678
2024
Q1 		$630K Buy
878,543
+36,529
+4% +$26.5K ﹤0.01% 3528
2023
Q4 		$716K Buy
842,014
+12,212
+1% +$11.8K ﹤0.01% 3474
2023
Q3 		$1.14M Buy
829,802
+45,086
+6% +$97.7K ﹤0.01% 3269
2023
Q2 		$1.98M Buy
784,716
+405,926
+107% +$860K ﹤0.01% 3117
2023
Q1 		$860K Buy
378,790
+28,433
+8% +$72.1K ﹤0.01% 3411
2022
Q4 		$490K Buy
350,357
+13,527
+4% +$22.7K ﹤0.01% 3665
2022
Q3 		$666K Buy
336,830
+268,734
+395% +$559K ﹤0.01% 3582
2022
Q2 		$106K Hold
68,096
– – ﹤0.01% 4570
2022
Q1 		$292K Hold
68,096
– – ﹤0.01% 4193
2021
Q4 		$382K Buy
+68,096
New +$704K ﹤0.01% 4178

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Geode Capital Management's VAXX Position: Q2 2024 in Review

Geode Capital Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 878,543 shares — an estimated $630K sold.

Geode Capital Management first reported a position in VAXX in Q4 2021 and held it in 10 quarters. The position peaked at $1.98M in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Geode Capital Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Geode Capital Management sold 878,543 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $630K.
  • Geode Capital Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 10 quarters.
  • Geode Capital Management's Vaxxinity, Inc. Class A Common Stock position peaked at $1.98M in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.